$CERS
CERUS CORP

2018 Q2 Form 10-Q Financial Statement

#000156459018018956 Filed on August 02, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q4 2017 Q2
Revenue $15.42M $16.24M $9.525M
YoY Change 61.89% 60.4% 2.96%
Cost Of Revenue $7.720M $9.130M $4.360M
YoY Change 77.06% 62.75% -12.38%
Gross Profit $7.700M $9.490M $5.165M
YoY Change 49.08% 109.96% 20.82%
Gross Profit Margin 49.94% 58.44% 54.23%
Selling, General & Admin $14.44M $12.51M $14.09M
YoY Change 2.46% 0.56% 13.57%
% of Gross Profit 187.49% 131.82% 272.8%
Research & Development $9.881M $7.780M $8.890M
YoY Change 11.15% -11.79% 3.89%
% of Gross Profit 128.32% 81.98% 172.12%
Depreciation & Amortization $380.0K $450.0K $430.0K
YoY Change -11.63% 4.65% -10.42%
% of Gross Profit 4.94% 4.74% 8.33%
Operating Expenses $24.32M $20.34M $23.04M
YoY Change 5.57% -4.51% 9.62%
Operating Profit -$12.57M -$10.85M -$16.20M
YoY Change -22.42% -35.34% -3.2%
Interest Expense $958.0K -$850.0K $501.0K
YoY Change 91.22% 88.89% -23.86%
% of Operating Profit
Other Income/Expense, Net -$652.0K $140.0K $2.997M
YoY Change -121.76% -83.53% -775.0%
Pretax Income -$13.22M -$11.56M -$13.21M
YoY Change 0.12% -21.41% -23.14%
Income Tax $59.00K -$70.00K $3.876M
% Of Pretax Income
Net Earnings -$13.28M -$11.49M -$17.08M
YoY Change -22.25% -14.92% -5.96%
Net Earnings / Revenue -86.13% -70.73% -179.35%
Basic Earnings Per Share -$0.10 -$0.10 -$0.16
Diluted Earnings Per Share -$0.10 -$0.10 -$0.16
COMMON SHARES
Basic Shares Outstanding 131.4M 105.0M
Diluted Shares Outstanding 131.4M 105.0M

Balance Sheet

Concept 2018 Q2 2017 Q4 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $111.9M $60.70M $50.90M
YoY Change 119.84% -10.31% -39.44%
Cash & Equivalents $17.03M $13.68M $20.53M
Short-Term Investments $97.60M $47.01M $30.60M
Other Short-Term Assets $4.970M $2.330M $3.300M
YoY Change 50.61% 29.16% -38.26%
Inventory $12.93M $14.46M $12.20M
Prepaid Expenses $1.221M
Receivables $11.39M $12.42M $7.900M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $141.2M $89.90M $74.30M
YoY Change 90.04% -4.47% -33.79%
LONG-TERM ASSETS
Property, Plant & Equipment $2.157M $2.119M $2.700M
YoY Change -20.11% -29.01% -16.04%
Goodwill $1.316M $1.316M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.011M $4.128M $4.600M
YoY Change -12.8% -0.48% 100.61%
Total Long-Term Assets $10.65M $8.346M $9.200M
YoY Change 15.74% -10.94% 11.66%
TOTAL ASSETS
Total Short-Term Assets $141.2M $89.90M $74.30M
Total Long-Term Assets $10.65M $8.346M $9.200M
Total Assets $151.8M $98.24M $83.50M
YoY Change 81.85% -5.06% -30.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.31M $10.97M $9.600M
YoY Change 17.78% 27.8% 33.52%
Accrued Expenses $12.51M $11.71M $9.300M
YoY Change 34.49% 4.4% -1.47%
Deferred Revenue $445.0K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.600M $5.500M
YoY Change -34.55% -9.84%
Total Short-Term Liabilities $28.06M $23.13M $25.30M
YoY Change 10.92% -13.97% -1.56%
LONG-TERM LIABILITIES
Long-Term Debt $26.30M $29.80M $11.90M
YoY Change 121.01% 140.32% -13.14%
Other Long-Term Liabilities $1.329M $609.0K $7.000M
YoY Change -81.01% -61.7% 416.22%
Total Long-Term Liabilities $1.329M $609.0K $18.90M
YoY Change -92.97% -61.7% 1293.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $28.06M $23.13M $25.30M
Total Long-Term Liabilities $1.329M $609.0K $18.90M
Total Liabilities $61.40M $59.30M $44.20M
YoY Change 38.92% 29.8% -3.51%
SHAREHOLDERS EQUITY
Retained Earnings -$748.5M -$721.3M
YoY Change 9.17%
Common Stock $839.3M $760.3M
YoY Change 5.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $90.44M $38.94M $39.30M
YoY Change
Total Liabilities & Shareholders Equity $151.8M $98.24M $83.50M
YoY Change 81.85% -5.06% -30.71%

Cashflow Statement

Concept 2018 Q2 2017 Q4 2017 Q2
OPERATING ACTIVITIES
Net Income -$13.28M -$11.49M -$17.08M
YoY Change -22.25% -14.92% -5.96%
Depreciation, Depletion And Amortization $380.0K $450.0K $430.0K
YoY Change -11.63% 4.65% -10.42%
Cash From Operating Activities -$8.930M -$10.04M -$13.00M
YoY Change -31.31% 3.4% -10.53%
INVESTING ACTIVITIES
Capital Expenditures -$100.0K $0.00 -$160.0K
YoY Change -37.5% -100.0% 100.0%
Acquisitions
YoY Change
Other Investing Activities -$6.770M -$4.610M $11.86M
YoY Change -157.08% -124.39% -298.33%
Cash From Investing Activities -$6.870M -$4.610M $11.68M
YoY Change -158.82% -124.65% -293.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 15.13M 11.33M 10.65M
YoY Change 42.07% 3676.67% 41.62%
NET CHANGE
Cash From Operating Activities -8.930M -10.04M -13.00M
Cash From Investing Activities -6.870M -4.610M 11.68M
Cash From Financing Activities 15.13M 11.33M 10.65M
Net Change In Cash -670.0K -3.320M 9.330M
YoY Change -107.18% -135.74% -171.44%
FREE CASH FLOW
Cash From Operating Activities -$8.930M -$10.04M -$13.00M
Capital Expenditures -$100.0K $0.00 -$160.0K
Free Cash Flow -$8.830M -$10.04M -$12.84M
YoY Change -31.23% 5.57% -11.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2157000
CY2018Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11388000
CY2018Q2 us-gaap Inventory Net
InventoryNet
12930000
CY2018Q2 us-gaap Other Assets Current
OtherAssetsCurrent
4970000
CY2018Q2 us-gaap Assets Current
AssetsCurrent
141198000
CY2018Q2 us-gaap Goodwill
Goodwill
1316000
CY2018Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
435000
CY2018Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2729000
CY2018Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4011000
CY2018Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
11307000
CY2018Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12508000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
23131000
CY2018Q2 us-gaap Secured Debt Current
SecuredDebtCurrent
3572000
CY2018Q2 us-gaap Secured Long Term Debt
SecuredLongTermDebt
26262000
CY2018Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
676000
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
445000
CY2018Q2 us-gaap Liabilities
Liabilities
61402000
CY2017Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
29798000
CY2018Q2 cers Accrual For Manufacturing And Development Payment Liability Noncurrent
AccrualForManufacturingAndDevelopmentPaymentLiabilityNoncurrent
5748000
CY2017Q4 cers Accrual For Manufacturing And Development Payment Liability Noncurrent
AccrualForManufacturingAndDevelopmentPaymentLiabilityNoncurrent
5766000
CY2018Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1329000
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
609000
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Liabilities
Liabilities
59304000
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
133000
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-417000
CY2018Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
839198000
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-748470000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
90444000
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
151846000
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
59000
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
23036000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
24318000
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
444000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2119000
CY2018Q2 us-gaap Assets
Assets
151846000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11712000
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
28063000
CY2018Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7720000
CY2017Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4360000
CY2018Q2 cers Gross Profit On Product Revenue
GrossProfitOnProductRevenue
7700000
us-gaap Operating Expenses
OperatingExpenses
47362000
us-gaap Operating Expenses
OperatingExpenses
45869000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-12571000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-16204000
CY2018Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-138000
CY2017Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-14000
CY2018Q2 us-gaap Interest Expense
InterestExpense
958000
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131352000
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
131352000
CY2018Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
9000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-320000
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13273000
CY2018Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
us-gaap Profit Loss
ProfitLoss
-27167000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
788000
us-gaap Share Based Compensation
ShareBasedCompensation
4908000
cers Non Cash Interest Expense
NonCashInterestExpense
537000
cers Non Cash Interest Expense
NonCashInterestExpense
285000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1000
cers Non Cash Tax Expense Benefit From Other Unrealized Gain Loss On Available For Sale Securities
NonCashTaxExpenseBenefitFromOtherUnrealizedGainLossOnAvailableForSaleSecurities
3825000
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
3466000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
775000
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-652000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-13282000
CY2017Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2997000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-17083000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2527000
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13223000
us-gaap Net Income Loss
NetIncomeLoss
-27167000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1128000
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13207000
CY2017Q4 us-gaap Inventory Net
InventoryNet
14457000
CY2017Q4 us-gaap Goodwill
Goodwill
1316000
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2330000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
89898000
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
536000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4128000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10974000
CY2017Q4 us-gaap Assets
Assets
98244000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
247000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12415000
CY2017Q2 cers Gross Profit On Product Revenue
GrossProfitOnProductRevenue
5165000
cers Gross Profit On Product Revenue
GrossProfitOnProductRevenue
13934000
CY2018Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
10087000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13930000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15050000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8054000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22744000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-237000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105044000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
128101000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
104308000
cers Gross Profit On Product Revenue
GrossProfitOnProductRevenue
8477000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-59000
CY2017Q2 us-gaap Interest Expense
InterestExpense
501000
us-gaap Interest Expense
InterestExpense
1873000
us-gaap Interest Expense
InterestExpense
1032000
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3512000
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
105044000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
128101000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
104308000
CY2017Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
124000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3618000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27054000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-31770000
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3876000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
113000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3911000
us-gaap Net Income Loss
NetIncomeLoss
-35681000
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-122000
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16959000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-27487000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35803000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2017Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
us-gaap Operating Income Loss
OperatingIncomeLoss
-25926000
us-gaap Operating Income Loss
OperatingIncomeLoss
-34297000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-30000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
us-gaap Profit Loss
ProfitLoss
-35681000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
904000
us-gaap Share Based Compensation
ShareBasedCompensation
4617000
CY2018Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
9881000
CY2018Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14437000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1085000
cers Increase Decrease In Accrued Liabilities And Other Noncurrent Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherNoncurrentLiabilities
-1457000
cers Increase Decrease In Manufacturing And Development Payment Liability
IncreaseDecreaseInManufacturingAndDevelopmentPaymentLiability
419000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
233000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29347000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
353000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
20749000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
38465000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
17363000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
2052000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9644000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17034000
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20526000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16531000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1027000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1064000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1458000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1587000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-704000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
154000
cers Increase Decrease In Accrued Liabilities And Other Noncurrent Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherNoncurrentLiabilities
553000
cers Increase Decrease In Manufacturing And Development Payment Liability
IncreaseDecreaseInManufacturingAndDevelopmentPaymentLiability
-148000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
216000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19255000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
145000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
75462000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
24002000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51605000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
4912000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
69117000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
65000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1930000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
73964000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9766000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3104000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2218000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements requires management to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, management evaluates its estimates, including those related to the nature and timing of satisfaction of performance obligations, the timing when the customer obtains control of products or services, the standalone selling price (&#8220;SSP&#8221;) of performance obligations, variable consideration, accounts receivable, inventory reserves, fair values of investments, stock-based compensation, intangible assets and goodwill, useful lives of intangible assets and property and equipment, income taxes, and accrued liabilities, among others. The Company bases its estimates on historical experience, future projections, and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ from those estimates under different assumptions or conditions.</p></div>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20219000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, available-for-sale securities and accounts receivable.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the Company&#8217;s investment policy, substantially all of the Company&#8217;s cash, cash equivalents and available-for-sale securities are maintained at major financial institutions of high credit standing. The Company monitors the financial credit worthiness of the issuers of its investments and limits the concentration in individual securities and types of investments that exist within its investment portfolio. Generally, all of the Company&#8217;s investments carry high credit quality ratings, which is in accordance with its investment policy. At June&#160;30, 2018, the Company does not believe there is significant financial risk from non-performance by the issuers of the Company&#8217;s cash equivalents and short-term investments.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Concentrations of credit risk with respect to trade receivables exist. On a regular basis, including at the time of sale, the Company performs credit evaluations of its significant customers that it expects to sell to on credit terms. Generally, the Company does not require collateral from its customers to secure accounts receivable. To the extent that the Company determines specific invoices or customer accounts may be uncollectible, the Company establishes an allowance for doubtful accounts against the accounts receivable on its unaudited condensed consolidated balance sheets and records a charge on its unaudited condensed consolidated statements of operations as a component of selling, general and administrative expenses.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company had two and three customers that accounted for more than 10% of the Company&#8217;s outstanding trade receivables at June&#160;30, 2018 and December&#160;31, 2017, respectively. These customers cumulatively represented approximately 62% and 53% of the Company&#8217;s outstanding trade receivables at June&#160;30, 2018 and December&#160;31, 2017, respectively. To date, the Company has not experienced collection difficulties from these customers.</p></div>
us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<div> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Guarantee and Indemnification Arrangements</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes the fair value for guarantee and indemnification arrangements issued or modified by the Company. In addition, the Company monitors the conditions that are subject to the guarantees and indemnifications in order to identify if a loss has occurred. If the Company determines it is probable that a loss has occurred, then any such estimable loss would be recognized under those guarantees and indemnifications. Some of the agreements that the Company is a party to contain provisions that indemnify the counter party from damages and costs resulting from claims that the Company&#8217;s technology infringes the intellectual property rights of a third party or claims that the sale or use of the Company&#8217;s products have caused personal injury or other damage or loss. The Company has not received any such requests for indemnification under these provisions and has not been required to make material payments pursuant to these provisions.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company generally provides for a one-year warranty on certain of its INTERCEPT blood-safety products covering defects in materials and workmanship. The Company accrues costs associated with warranty obligations when claims become known and are estimable. The Company has not experienced significant or systemic warranty claims nor is it aware of any existing current warranty claims. Accordingly, the Company had not accrued for any future warranty costs for its products at June&#160;30, 2018 and December&#160;31, 2017.</p></div>
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2018Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2017Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2018Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20826000
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19359000
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15420000
CY2017Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9525000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
28984000
us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
The Company invoices its customers based upon the payment terms in the contracts, which is generally from 30 to 60 days.
CY2018Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2017Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
200000
us-gaap Revenue Practical Expedient Remaining Performance Obligation
RevenuePracticalExpedientRemainingPerformanceObligation
true
CY2018Q2 us-gaap Restricted Cash
RestrictedCash
2500000
CY2018Q2 cers Cumulative Outstanding Trade Receivables Number Of Major Customers
CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers
2
CY2017Q4 cers Cumulative Outstanding Trade Receivables Number Of Major Customers
CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers
3
cers Work In Process Inventory Life Period
WorkInProcessInventoryLifePeriod
P1Y
CY2018Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
300000
CY2017Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
100000
CY2018Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1580000
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1480000
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P10Y
CY2018Q2 cers Longterm Debt Maturities Repayments Of Interest In Next Twelve Months
LongtermDebtMaturitiesRepaymentsOfInterestInNextTwelveMonths
1381000
CY2018Q2 cers Long Term Debt Maturities Repayments Of Interest In Year Two
LongTermDebtMaturitiesRepaymentsOfInterestInYearTwo
2453000
CY2018Q2 cers Long Term Debt Maturities Repayments Of Interest In Year Three
LongTermDebtMaturitiesRepaymentsOfInterestInYearThree
1677000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18555000
cers Product Warranty Term
ProductWarrantyTerm
P1Y
CY2018Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
0
CY2017Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
0
CY2018Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
30000000
CY2018Q2 cers Long Term Debt Maturities Repayments Of Interest In Year Four
LongTermDebtMaturitiesRepaymentsOfInterestInYearFour
885000
CY2018Q2 cers Long Term Debt Maturities Repayments Of Interest In Year Five
LongTermDebtMaturitiesRepaymentsOfInterestInYearFive
2553000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
97000
CY2018Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
96121000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
44514000
CY2018Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
417000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
97000
CY2018Q2 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2017Q2 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2018Q2 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
0
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
0
CY2017Q2 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
3400000
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
3500000
CY2017Q2 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2018Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2843000
CY2017Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4299000
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
10158000
CY2018Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
7857000
CY2018Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
8571000
CY2018Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
8572000
CY2018Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
5000000
CY2018Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
98076000
CY2018Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
417000
CY2018Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
97659000
CY2017Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
50868000
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
97000
CY2017Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
50771000
CY2018Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
51079000
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
38836000
CY2018Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
46997000
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
12032000
CY2018Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
50902000
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
38781000
CY2018Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
46757000
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
11990000
CY2018Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
96121000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
44514000
CY2018Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
417000
CY2018Q2 cers Long Term Debt Maturities Repayments Of Principal And Interest In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearFour
9457000
CY2018Q2 cers Long Term Debt Maturities Repayments Of Principal And Interest In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearFive
7553000
CY2018Q2 cers Long Term Debt Maturities Repayments Of Principal And Interest
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterest
38949000
cers Minimum Term Of Non Cancelable Operating Leases
MinimumTermOfNonCancelableOperatingLeases
P1Y
cers Expiration Of Non Cancelable Operating Leases Maximum Year
ExpirationOfNonCancelableOperatingLeasesMaximumYear
2029
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
925000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
3265000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2318000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2167000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
2191000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
16492000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
27358000
cers Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
6400000
CY2018Q2 cers Accrual For Manufacturing Of Entity Products
AccrualForManufacturingOfEntityProducts
5652000
CY2017Q4 cers Accrual For Manufacturing Of Entity Products
AccrualForManufacturingOfEntityProducts
4687000
CY2017Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
231000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1

Files In Submission

Name View Source Status
0001564590-18-018956-index-headers.html Edgar Link pending
0001564590-18-018956-index.html Edgar Link pending
0001564590-18-018956.txt Edgar Link pending
0001564590-18-018956-xbrl.zip Edgar Link pending
cers-10q_20180630.htm Edgar Link pending
cers-20180630.xml Edgar Link completed
cers-20180630.xsd Edgar Link pending
cers-20180630_cal.xml Edgar Link unprocessable
cers-20180630_def.xml Edgar Link unprocessable
cers-20180630_lab.xml Edgar Link unprocessable
cers-20180630_pre.xml Edgar Link unprocessable
cers-ex101_154.htm Edgar Link pending
cers-ex102_153.htm Edgar Link pending
cers-ex103_152.htm Edgar Link pending
cers-ex104_150.htm Edgar Link pending
cers-ex105_149.htm Edgar Link pending
cers-ex106_151.htm Edgar Link pending
cers-ex311_7.htm Edgar Link pending
cers-ex312_11.htm Edgar Link pending
cers-ex321_10.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gsimnqmvpo4j000001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending